Tilray Stock News

Shares of several cannabis stocks, including Aurora Cannabis Inc (NASDAQ: ACB), Canopy Growth Corp (NASDAQ: CGC), Cronos Group Inc (NASDAQ: CRON), Sundial Growers Inc (NASDAQ: SNDL) and Tilray Inc

Canopy Growth Corporation (NASDAQ: CGC) and Tilray, Inc (NASDAQ: TLRY) gapped up slightly higher on Wednesday after running up to 7.43% and 12.87%, respectively, in the after-hours trading session on

WallStreetBets continues to be a den of meme traders and we're checking in on the top trending stocks in the Reddit community for Wednesday. The post 8 Top Stocks Trending on Reddit WallStreetBets Tod

Marijuana stocks are making major moves on Wednesday as investors react to news of a couple of mergers taking place in the sector. The post Marijuana Stocks: The M&A News Lighting Up TLRY, CGC, ACB an

Canadian Pot Stocks For Active Traders In 2022 The post Top Canadian Marijuana Stocks To Watch Before April appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Indus

Cannabis Industry Updates and Current Events 2022 The post Cannabis Industry Trends To Watch For In 2022 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks, and look at how the cannabis industry is evolving as we mak

TLRY stock has tumbled 80% over the past year, but now expectations for Tilray are even higher after a milestone of net income in Q2 FY22. The post Tilray Stock Isn't a Buy Until It Proves Its Profita

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. The cannabis industry has exploded. Since the first states legalized cannabis for recreational use in 2012, the market has enjoyed massive growth year after year. Led by heavy-hitters like Tilray Inc. (NASDAQ: TLRY ) and Canopy Growth Corp. (NASDAQ: CGC ), the legal market brought in $17.5 billion in 2020. That’s a 46% increase from 2019. And by 2025, the industry should pull in revenue of $43 billion with a compound annual growth rate (CAGR) of 16%, according to research firm New Frontier Data. Despite the dominance of giants like Tilray, the burgeoning cannabis market is considered by many to be ripe for disruption. New entries of all sizes can succeed in the business, from mom-and-pop retailers to large-scale producers. Each day brings new innovations, and with … Full story available on Benzinga.com

Shareholders are now getting a two-companies-for-the-price-of-one deal with TLRY stock, but whether that's a good or not thing is debatable. The post If You're Going to Hold Tilray Stock, You'd Better

Canadian cannabis player, Hexo (HEXO) acknowledged on Monday that the company defaulted on some of its debt due May 2023

Remember how exciting it was when Canadian company Tilray bought out competitor Aphria? At the time, it was the cannabis-market merger of a lifetime. TLRY stock was supposed to soar to all-time highs. However, people''s pot stock dreams met reality and went up in smoke. Even with Aphria''s assets, Tilray still hasn''t been able to turn the tide of Wall Street sentiment. Taking a closer look at what Tilray has been up to lately, we can make a persuasive argument that TLRY stock is severely undervalued. Knowing this, contrarian investors might start accumulating shares. But hold your horses. There''s a fresh bulletin that''s bound to change the equation and when all is said and done, it could force prospective investors to reevaluate their strategies. A Closer Look at TLRY Stock A year ago, when it seemed as if TLRY stock was destined to break through $30, it felt as if the sky was the limit. Those were good times, weren''t they? We should however bear in mind that early 2021 was a time when meme stock traders were pushing all sorts of downtrodden stocks to short-term highs.

The company''s recent moves have me wondering just how safe this stock really is.

Who is the person behind the largest Canadian cannabis company in the world? That would be Irwin D. Simon, chairman and CEO of Tilray Brands Inc. (NASDAQ: TLRY ). After some 30 years in executive roles at various consumer packaged goods companies from organic and natural foods to personal care initiatives, Simon landed on cannabis, at least for now. This year, at the upcoming Benzinga Cannabis Capital Conference , to be held on April 20 and April 21 at the Fontainebleau Miami Beach Hotel in Florida, Simon will deliver the keynote speech and share his vast knowledge and experience across this booming industry. Prior to joining Tilray in May 2021, Simon was known as the visionary who transformed Aphria into a profitable global cannabis company with leading market share brands. When the two large marijuana operators decided to join their forces and create a company with a combined market cap of $3.3 billion last spring, Simon was essential to the deal . Under the merger agreement, Simon was elected as CEO of the resulting company, which was projected to generate roughly $81 million in annual pre-tax cost synergies within the following eighteen months. ‘I’m Not A Quitter’ Considering that Simon faced considerable challenges when he joined Aphria in 2018 , which at the time was affected by a short-sellers report , it made perfect sense that Tilray wanted a person like him at its helm. "I remember calling my wife and telling her, ''What am I doing?" Simon told Bloomberg . "But I ''m not a quitter .

Monday''s top analyst upgrades and downgrades included Broadcom, Costco Wholesale, DraftKings, Exxon Mobil, Foot Locker, Marvell Technology, Nvidia, Payoneer Global, Philip Morris International, Pure Storage, Rivian Automotive, SoFi Technologies, Splunk and Tilray Brands.